Blood-based DNA methylation profiling for the detection of ovarian cancer
Authors:
- 9 September 2022
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 167 (2) , 295-305
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Staging classification for cancer of the ovary, fallopian tube, and peritoneumInternational Journal of Gynecology & Obstetrics, 2013
- A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNAGynecologic Oncology, 2013
- DNA methylation profiling in the clinic: applications and challengesNature Reviews Genetics, 2012
- Epigenetic variation during the adult lifespan: cross‐sectional and longitudinal data on monozygotic twin pairsAging Cell, 2012
- Epigenome-Wide Scans Identify Differentially Methylated Regions for Age and Age-Related Phenotypes in a Healthy Ageing PopulationPLOS Genetics, 2012
- High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation PathwayClinical Cancer Research, 2012
- Effect of Screening on Ovarian Cancer MortalityJAMA, 2011
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- Diagnostic Markers for Early Detection of Ovarian CancerClinical Cancer Research, 2008
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003